IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma

Go back to IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
(NASDAQ: INAB) Delayed: 1.34 --0 (-0%)
Previous Close $1.34    52 Week High
Open $1.34    52 Week Low
Day High $1.34    P/E N/A 
Day Low $1.34    EPS
Volume